My breast cancer survival story

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

April is STI Awareness Month, and as such, we are focusing on testing and increase of STDs in the pandemic, especially how women and minorities are affected.

A recent study in Microorganisms reveals that Metronidazole treatment failure in bacterial vaginosis is linked to elevated activated T- and dendritic-cell subsets, potentially heightening susceptibility to HIV.

On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.

In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.

A recent study unveils the diagnostic potential of the Convergences pelvic pain (PP) score for identifying central sensitization in women with chronic pelvic pain.